Patient support programmes (PSPs) hold great promise for oncology patients, healthcare professionals, and pharma companies by bridging the gap between clinic and home care.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho